Nova One Advisor
Digestive & Intestinal Remedies Market Size Report, 2022-2030

Digestive & Intestinal Remedies Market Size, Share & Trends Analysis Report By Type, By Distribution Channel (Online, Offline) - Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2022-2030

Status: Published Category: Healthcare Insight Code: 6926 Format: PDF / PPT / Excel

Content

The global Digestive & Intestinal Remedies market size was estimated at USD 18.4 billion in 2021 and is expected to surpass around USD 30.11 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2022 to 2030.

Key Takeaways:

  • By Type, the U.S. Digestive & Intestinal Remedies market was valued at USD 4.45 Billion in 2021 and expected to witness growth at a CAGR of 3.20% from 2022 to 2030.
  • Asia Pacific is expected to register the fastest CAGR of 5.9% from 2022 to 2030 owing to rising demand for digestives & intestinal remedies due to the increasing prevalence of GI illness disease
  • The digestive medicines accounted for the largest revenue share of over 50.2% in 2021 owing to the increasing demand for these drugs due to rising health issues
  • The offline segment dominated the market with the highest share of 70.2% in 2021 owing to its increasing sales
  • The remedies against gastrointestinal complaints segment will register the highest growth at 4.7% from 2022 to 2030 due to its growing cases of gastrointestinal disease

Digestive medicines are the most common over the counter medicines purchased by people. Moreover, physicians recommend the use of these medicines only after minor health issues such as acidity and other digestive problems. But in several countries, these medicines are sold directly to the patients without prescription as per their rules and regulations.

The market is majorly driven by high demand for over-the-counter products such as zientac, omez, and others. There is an increase in gastrointestinal disorders cases among people. Moreover, increasing cases of inflammatory bowel disease, constipation, irritable bowel syndrome, and gastroesophageal reflux illness are other factors that in turn are boosting market growth over the forecast period.

The market growth is driven by the developments and expansion of fast-food joints and the food service industry. Due to the expansion of hotels, restaurants, and junk food places across the world, consumption of oily, spicy, and unhygienic food has increased extremely. Moreover, increasing disposable income and a hectic lifestyle are facilitating the trend of eating out. This significantly leads to digestive and intestinal problems such as acidity, upset stomach, inflammations, etc., and increases consumption of digestive and intestinal remedies.

During the COVID-19 pandemic, the sales of digestive and intestinal remedies were reduced globally. Lockdown measures to control the spread of COVID-19 and better hygiene have frozen the spread of seasonal illnesses, which has reduced the sales of over-the-counter medicines. Various pharmaceutical companies have displayed quarterly earnings reports which showed that a decrease in digestive and intestinal remedies has affected their bottom line sales in the market.

 The digestive medicines accounted for the largest revenue share of over 50% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period.

The offline segment dominated the market with the highest share of over 70% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period.

North America dominated the market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is driving the market growth. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period.

Report Scope of the Digestive & Intestinal Remedies Market

Report Coverage

Details

Market Size

US$ 30.11 Billion by 2030

Growth Rate

CAGR of 5.9% from 2022 to 2030

Largest Market

North America

Fastest Growing Market

Asia Pacific

Base Year

2021

Forecast Period

2022 to 2030

Segments Covered

 Type, distribution channel and Region,

Companies Mentioned

 Bayer Healthcare; Johnson & Johnson; GlaxoSmithKline Plc; Procter & Gamble Co; Sanofi; Boehringer Ingelheim GmbH; Reckitt Benckiser; Group Plc (RB); Abbott Laboratories Inc.; Takeda Pharmaceutical Co Ltd; Menarini Group

 

Type Insights

The digestive medicines accounted for the largest revenue share of over 50.2% in 2021 owing to the increasing demand for these drugs due to rising health issues. The rising aging population is also another key factor driving the segment growth. Moreover, altering lifestyles and diets has also increased the demand for digestive remedies products. Hence, owing to these reasons the segment is estimated to show growth over the estimated period. 

The remedies against gastrointestinal complaints segment will register the highest growth at 3.7% from 2022 to 2030 due to its growing cases of gastrointestinal disease. Increasing healthcare expenditure, and growth in the geriatric population are major factors boosting segment growth. The growing burden of gastrointestinal disorders in various countries is also making the market more lucrative. 

Distribution Channel Insights

The offline segment dominated the market with the highest share of 70.2% in 2021. The demand for digestives & intestinal remedies is rising among customers due to more sustainability offered by these offline stores than any other channel. Hence the segment is projected to show growth during the assessment period. 

The online segment is estimated to showcase significant growth of CAGR 3.8% over the forecast period. Digestives & intestinal remedies can be purchased at a low price via online platforms. Such channels can provide various benefits such as coupon benefits and other offers. Moreover, the rising incidence of app-based sellers that are significantly popular is also driving the segment over the forecast period.

Regional Insights

North America dominated the digestives & intestinal remedies market and accounted for around 45% revenue share in 2021 due to the growing number of gastrointestinal diseases in this region. Also, the growing geriatric and obese population in this region is expected to drive market growth over the forecast period. Increasing research and development activities along with the presence of key market players are other factors boosting market growth over the forecast period. 

The Asia Pacific is expected to witness a CAGR of 5.9% from 2022 to 2030. This can be credited to the increasing demand for digestives & intestinal remedies medicine in this region. The rising prevalence of GI illnesses has led to rising demand for digestives & intestinal remedies types. Hence this region is estimated to show the fastest growth rate over the forecast period.

 

Some of the prominent players in the Digestive & Intestinal Remedies Market include:

  • Bayer Healthcare
  • Johnson & Johnson
  • GlaxoSmithKline Plc
  • Procter & Gamble Co
  • Sanofi
  • Boehringer Ingelheim GmbH
  • Reckitt Benckiser Group Plc (RB)
  • Abbott Laboratories Inc.
  • Takeda Pharmaceutical Co Ltd
  • Menarini Group

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Digestive & Intestinal Remedies market

  • Type
    • Digestive Medicines
    • Remedies Against Gastrointestinal Complaints
    • Natural And Synthetic Agents
  • Distribution Channel
    • Online
    • Offline

By Geography

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • United Kingdom
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Southeast Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa (MEA)

  • GCC
  • North Africa
  • South Africa
  • Rest of Middle East & Africa

Key Points Covered in Digestive & Intestinal Remedies Market Study:

  • Growth of Digestive & Intestinal Remedies in 2022
  • Market Estimates and Forecasts (2017-2030)
  •  Brand Share and Market Share Analysis
  •  Key Drivers and Restraints Shaping Market Growth
  •  Segment-wise, Country-wise, and Region-wise Analysis
  •  Competition Mapping and Benchmarking
  •  Recommendation on Key Winning Strategies
  •  COVID-19 Impact on Demand for Digestive & Intestinal Remedies and How to Navigate
  •  Key Product Innovations and Regulatory Climate
  •  Digestive & Intestinal Remedies Consumption Analysis
  •  Digestive & Intestinal Remedies Production Analysis
  •  Digestive & Intestinal Remedies and Management
  • Insight Code: 6926
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2022
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034